Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion type Assertion NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_head.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion description "[Collectively, these findings suggested that the antimetastatic properties of CLT in breast cancer were due to the inhibition of MMPs, which might be associated with a downregulation of Runx2 transcriptional activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_provenance.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion evidence source_evidence_literature NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_provenance.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion SIO_000772 25190326 NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_provenance.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion wasDerivedFrom befree-2016 NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_provenance.
- NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_assertion wasGeneratedBy ECO_0000203 NP1217162.RA_oSzGq6vu1yv-D1UR0qGbUu16xZG1Y6L8xoujKkknb4130_provenance.